On July 1, 2022, the purchase of the Seahorse XF PRO cell metabolism analytical system (Agilent) was finalized. The system is used for live assays of metabolic pathways in in vitro cultures and isolated mitochondria.
The Seahorse XF PRO features the most advanced technology for analysis of cell metabolism aimed at understanding the fate, efficiency and functions of cells in various conditions, which enhances efficiency of screening of potential drugs and fast profiling of their effect on energetic metabolism of the cell.
Studies within CEPHARES at the Maj Institute of Pharmacology will be carried out to elucidate cellular changes in the course of neuropsychiatric and neurodegenerative diseases.
